2014 ESC 立场声明:心血管疾病一级预防应用阿司匹林治疗

2014-07-22 欧洲心脏病学会 J Am Coll Cardiol. 2014 Jul 22;64(3):319-327.

2014年7月,欧洲心脏病学会(ESC)发布了关于应用阿司匹林治疗用于初级心血管疾病预防的意见书。

中文标题:

2014 ESC 立场声明:心血管疾病一级预防应用阿司匹林治疗

英文标题:

Aspirin Therapy in Primary Cardiovascular Disease Prevention: A Position Paper of the European Society of Cardiology Working Group on Thrombosis.

发布机构:

欧洲心脏病学会

发布日期:

2014-07-22

简要介绍:

2014年7月,欧洲心脏病学会(ESC)发布了关于应用阿司匹林治疗用于初级心血管疾病预防的意见书。

相关资料下载:
[AttachmentFileName(sort=100, fileName=2014 ESC 立场声明:心血管疾病一级预防应用阿司匹林治疗)] GetToolGuiderByIdResponse(projectId=1, id=b3c271c0010926f3, title=2014 ESC 立场声明:心血管疾病一级预防应用阿司匹林治疗, enTitle=Aspirin Therapy in Primary Cardiovascular Disease Prevention: A Position Paper of the European Society of Cardiology Working Group on Thrombosis., guiderFrom=J Am Coll Cardiol. 2014 Jul 22;64(3):319-327., authorId=null, author=, summary=2014年7月,欧洲心脏病学会(ESC)发布了关于应用阿司匹林治疗用于初级心血管疾病预防的意见书。, cover=, journalId=null, articlesId=null, associationId=62, associationName=欧洲心脏病学会, associationIntro=是目前在欧洲居于首要地位的心脏病学会,会员超过70000人、提供更新指南、调查数据、组织学术会议,ESC年会是心血管领域最大的会议。下设5个分会(超声心动图学会、心律学会、心衰学会、预防与康复学会及介入学会)。提供指南较全面,按年份排列。现提供有手机板本。, copyright=0, guiderPublishedTime=Tue Jul 22 08:00:00 CST 2014, originalUrl=http://guide.medlive.cn/guideline/6655, linkOutUrl=, content=2014年7月,欧洲心脏病学会(ESC)发布了关于应用阿司匹林治疗用于初级心血管疾病预防的意见书。, tagList=[TagDto(tagId=270, tagName=ESC), TagDto(tagId=2930, tagName=一级预防), TagDto(tagId=659, tagName=阿司匹林), TagDto(tagId=2930, tagName=一级预防)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=35, categoryName=预防医学, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3180, appHits=57, showAppHits=0, pcHits=1917, showPcHits=1505, likes=167, shares=4, comments=2, approvalStatus=1, publishedTime=Tue Jul 22 00:00:00 CST 2014, publishedTimeString=2014-07-22, pcVisible=1, appVisible=1, editorId=null, editor=milly, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=null, createdTime=Tue Jul 22 00:00:00 CST 2014, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 19:40:49 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2014 ESC 立场声明:心血管疾病一级预防应用阿司匹林治疗)])
2014 ESC 立场声明:心血管疾病一级预防应用阿司匹林治疗
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=122184, encodeId=6868122184b5, content=己拜读,受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 11 09:23:00 CST 2016, time=2016-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=122185, encodeId=f1771221854e, content=己拜读,受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 11 09:23:00 CST 2016, time=2016-09-11, status=1, ipAttribution=)]
    2016-09-11 1e10c84am36(暂无匿称)

    己拜读,受益匪浅

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=122184, encodeId=6868122184b5, content=己拜读,受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 11 09:23:00 CST 2016, time=2016-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=122185, encodeId=f1771221854e, content=己拜读,受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 11 09:23:00 CST 2016, time=2016-09-11, status=1, ipAttribution=)]
    2016-09-11 1e10c84am36(暂无匿称)

    己拜读,受益匪浅

    0